Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer-Reference-Cited by-同舟云学术

Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer

Published:2012-03-06 Issue:14 Volume:72 Page:1491-1505
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Isaacs John T.,D'Antonio Jason M.,Chen Shuangling,Antony Lizamma,Dalrymple Susan P.,Ndikuyeze Georges H.,Luo Jun,Denmeade Samuel R.

Funder

NIH

NIH Prostate SPORE

The Maryland Stem Cell Research Fund

The One-in-Six Foundation, Akron, OH

Urology Training Grant NIH

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.22504/fullpdf

Reference45 articles.

1. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?;Litvinov;J Clin Endocrinol Metab,2003

2. Androgen Receptor (AR) suppresses human prostate epithelial cell proliferation via AR/β-Catenin/TCF-4 complex inhibition of c-Myc transcription;Vander Griend;PLos-one,2012

3. Abiraterone and increased survival in metastatic prostate cancer;Bono;N Engl J Med,2011

4. Molecular determinants of resistance to antiandrogen therapy;Chen;Nat Med,2004

5. Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program;Shah;Cancer Res,2004

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic response of prostate cancer cells to carbon ion and photon irradiation with focus on androgen receptor and TP53 signaling;Radiation Oncology;2024-07-02

2. The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and -agonist to stimulate growth of target cells;Cell Communication and Signaling;2024-04-08

3. Updates on Overcoming Bicalutamide Resistance: A Glimpse into Resistance to a Novel Antiandrogen;ACS Pharmacology & Translational Science;2024-03-07

4. Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial;Nature Communications;2024-01-02

5. Does testosterone replacement therapy increase the risk of conversion to treatment in patients with prostate cancer on active surveillance?;Urologic Oncology: Seminars and Original Investigations;2023-10